Talk to the Institute
Published mark

SUTRO BIOPHARMA, INC.

NASDAQ: STRO. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5
SEC CIK
0001382101
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
Apr 22, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Jane Chung, R.Ph.Since Apr 22, 2026
Chair
Not published
Independent
8 / 99 directors published
Published claims
282 distinct sources
Evidence records
70 pinned
Source conflicts
0None open

Built from 2 distinct sources and 7 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

GC CHANGED

David Pauling, J.D., M.A. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22.

EffectiveEffective Apr 22, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Administrative Officer and General CounselDavid Pauling, J.D., M.A.Apr 2026currentSource reportedE3
Chief Financial OfficerGregory ChowApr 2026currentSource reportedE4
Chief Scientific OfficerHans-Peter Gerber, Ph.D.Apr 2026currentSource reportedE5
Chief Executive Officer and DirectorJane Chung, R.Ph.Apr 2026currentSource reportedE6

Board of directors

Evidence

9 directors published. 8 of 9 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Connie MatsuiIndependent2019Nominating and GovernanceSource reportedE2
Daniel H. PetreeIndependent2009CompensationCompensation; Nominating and GovernanceNominating and GovernanceSource reportedE2
Heidi HunterIndependent2021AuditSource reportedE2
James PanekIndependent2020Nominating and Governance, chairNominating and Governance · ChairSource reportedE2
Jane Chung, R.Ph.Not independent2025None publishedSource reportedE2
Jon Wigginton, M.D.Independent2020None publishedSource reportedE2
Joseph M. LobackiIndependent2017AuditAudit; Compensation · ChairCompensation, chairSource reportedE2
Michael Dybbs, Ph.D.Independent2018None publishedSource reportedE2
Sukhi JagpalIndependent2024Audit, chairAudit · ChairSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditSukhi JagpalSukhi Jagpal, Heidi Hunter, Joseph M. LobackiNot described in the published record
Audit · ChairNot publishedSukhi JagpalNot described in the published record
Audit; Compensation · ChairNot publishedJoseph M. LobackiNot described in the published record
CompensationJoseph M. LobackiJoseph M. Lobacki, Daniel H. PetreeNot described in the published record
Compensation; Nominating and GovernanceNot publishedDaniel H. PetreeNot described in the published record
Nominating and GovernanceJames PanekJames Panek, Connie Matsui, Daniel H. PetreeNot described in the published record
Nominating and Governance · ChairNot publishedJames PanekNot described in the published record
Committee RecordAudit: Chair Sukhi Jagpal; Members Sukhi Jagpal (Chair); Heidi Hunter; Joseph M. Lobacki
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_record:18
Committee AppointmentSukhi Jagpal: chair, Audit
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:19
Committee AppointmentHeidi Hunter: member, Audit
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:20
Committee AppointmentJoseph M. Lobacki: member, Audit
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:21
Committee RecordCompensation: Chair Joseph M. Lobacki; Members Joseph M. Lobacki (Chair); Daniel H. Petree
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_record:22
Committee AppointmentJoseph M. Lobacki: chair, Compensation
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:23
Committee AppointmentDaniel H. Petree: member, Compensation
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:24
Committee RecordNominating and Governance: Chair James Panek; Members James Panek (Chair); Connie Matsui; Daniel H. Petree
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_record:25
Committee AppointmentJames Panek: chair, Nominating and Governance
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:26
Committee AppointmentConnie Matsui: member, Nominating and Governance
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:27
Committee AppointmentDaniel H. Petree: member, Nominating and Governance
Source reportedE7
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:28

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerJane Chung, R.Ph., Chief Executive Officer and Director, from Apr 22, 2026
Source reportedE6
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:17
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingSTRO (NASDAQ)
Source reportedE1
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:security_listing:29
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameSUTRO BIOPHARMA, INC.
Source reportedE1
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
7 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    SUTRO BIOPHARMA, INC. DEF 14A 2026-04-22
    sec proxy. Published Apr 22, 2026. Retrieved Apr 25, 2026. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    STRO DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    STRO DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    STRO DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    STRO DEF 14A executive officers
    sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    Audit
    board_seats. board seats. Cited by 11 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • David Pauling, J.D., M.A. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22.
  • Gregory Chow executive of SUTRO BIOPHARMA, INC., effective 2026-04-22.
  • Hans-Peter Gerber, Ph.D. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22.
  • Jane Chung, R.Ph. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22.
  • Jane Chung, R.Ph. seat on SUTRO BIOPHARMA, INC., effective 2025-01-01.
  • Sukhi Jagpal seat on SUTRO BIOPHARMA, INC., effective 2024-01-01.
  • Audit · Chair committee of SUTRO BIOPHARMA, INC., effective 2024-01-01.
  • Sukhi Jagpal member of Audit · Chair, effective 2024-01-01.
  • Heidi Hunter seat on SUTRO BIOPHARMA, INC., effective 2021-01-01.
  • Heidi Hunter member of Audit, effective 2021-01-01.
  • James Panek seat on SUTRO BIOPHARMA, INC., effective 2020-01-01.
  • Jon Wigginton, M.D. seat on SUTRO BIOPHARMA, INC., effective 2020-01-01.
  • Nominating and Governance · Chair committee of SUTRO BIOPHARMA, INC., effective 2020-01-01.
  • James Panek member of Nominating and Governance · Chair, effective 2020-01-01.
  • Connie Matsui seat on SUTRO BIOPHARMA, INC., effective 2019-01-01.
  • Connie Matsui member of Nominating and Governance, effective 2019-01-01.
  • Michael Dybbs, Ph.D. seat on SUTRO BIOPHARMA, INC., effective 2018-01-01.
  • Joseph M. Lobacki seat on SUTRO BIOPHARMA, INC., effective 2017-01-01.
  • Audit; Compensation · Chair committee of SUTRO BIOPHARMA, INC., effective 2017-01-01.
  • Joseph M. Lobacki member of Audit; Compensation · Chair, effective 2017-01-01.
  • Daniel H. Petree seat on SUTRO BIOPHARMA, INC., effective 2009-01-01.
  • Compensation; Nominating and Governance committee of SUTRO BIOPHARMA, INC., effective 2009-01-01.
  • Daniel H. Petree member of Compensation; Nominating and Governance, effective 2009-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/sutro-biopharma-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership4
  4. Board9
  5. Committees7
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people12
  17. Subject and corrections6
  18. Evidence7
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5
  • Cite this recordSUTRO BIOPHARMA, INC.
  • Copy canonical URLregistry.alpha.ac/companies/sutro-biopharma-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    SUTRO BIOPHARMA, INC.Company
  • David Pauling, J.D., M.A.Person
  • Gregory ChowPerson
  • Hans-Peter Gerber, Ph.D.Person
  • Jane Chung, R.Ph.Person
  • Connie MatsuiPerson
  • Daniel H. PetreePerson
  • Heidi HunterPerson
  • James PanekPerson
  • Jon Wigginton, M.D.Person
  • Joseph M. LobackiPerson
  • Michael Dybbs, Ph.D.Person
  • Sukhi JagpalPerson
  • Sections
    OverviewSUTRO BIOPHARMA, INC.
  • MonitoringSUTRO BIOPHARMA, INC.
  • LeadershipSUTRO BIOPHARMA, INC.
  • BoardSUTRO BIOPHARMA, INC.
  • CommitteesSUTRO BIOPHARMA, INC.
  • Control and votingSUTRO BIOPHARMA, INC.
  • Authority to actSUTRO BIOPHARMA, INC.
  • FinancialsSUTRO BIOPHARMA, INC.
  • GovernanceSUTRO BIOPHARMA, INC.
  • RiskSUTRO BIOPHARMA, INC.
  • AI oversightSUTRO BIOPHARMA, INC.
  • LegalSUTRO BIOPHARMA, INC.
  • CompensationSUTRO BIOPHARMA, INC.
  • Other published claimsSUTRO BIOPHARMA, INC.
  • Coverage gapsSUTRO BIOPHARMA, INC.
  • Linked peopleSUTRO BIOPHARMA, INC.
  • Subject and correctionsSUTRO BIOPHARMA, INC.
  • EvidenceSUTRO BIOPHARMA, INC.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.